180 Life Sciences Corp. (NASDAQ: ATNF)
$1.9600
+0.0200 ( -1.01% ) 32.1K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.9600
Previous close
$1.9400
Volume
32.1K
Market cap
$3.91M
Day range
$1.8160 - $2.1900
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Feb 20, 2024 |
| 8-k | 8K-related | 17 | Feb 16, 2024 |
| 8-k | 8K-related | 15 | Jan 29, 2024 |
| 8-k | 8K-related | 17 | Jan 17, 2024 |
| 8-k | 8K-related | 13 | Jan 16, 2024 |
| 4 | Insider transactions | 1 | Dec 28, 2023 |
| def | Proxies and info statements | 7 | Dec 26, 2023 |
| 8-k | 8K-related | 13 | Dec 21, 2023 |
| 8-k | 8K-related | 13 | Dec 20, 2023 |
| 4 | Insider transactions | 1 | Dec 18, 2023 |